This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
NAT-LEVETIRACETAM
NATCO PHARMA (CANADA) INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is NAT-LEVETIRACETAM discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that NAT-LEVETIRACETAM 250MG has been permanently discontinued (last updated December 6, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is NAT-LEVETIRACETAM not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
LEVETIRACETAM
SANIS HEALTH INC
ABBOTT-LEVETIRACETAM
ABBOTT LABORATORIES, LIMITED
AVA-LEVETIRACETAM
AVANSTRA INC
TORRENT-LEVETIRACETAM
TORRENT PHARMACEUTICALS LIMITED
Other Products
JAMP-LEVETIRACETAM
JAMP PHARMA CORPORATION
KEPPRA
UCB CANADA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-06-30
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02440202
Strength
250MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
LEVETIRACETAM
Tier
Unrated
Last Updated
2025-07-03
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
NAT-LEVETIRACETAM has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from NATCO PHARMA (CANADA) INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
250MG · DIN 02494132
1MG · DIN 02417855
2.5MG · DIN 02492814
5MG · DIN 02492822
100MG · DIN 02496895
25MG · DIN 02496887
62.5MG · DIN 02467984
125MG · DIN 02467992
20MG · DIN 02496488
10MG · DIN 02496461
40MG · DIN 02409038
20MG · DIN 02409011